Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: Implications for clinical use
- 30 June 1985
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 20 (6) , 684-687
- https://doi.org/10.1016/0006-3223(85)90105-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind EvaluationThe British Journal of Psychiatry, 1983
- Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefitNeurology, 1982
- The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applicationsJournal of Pharmacy and Pharmacology, 1981
- Determination of tranylcypromine in human plasma and urine using high-resolution gas—liquid chromatography with nitrogen-sensitive detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO ?type B? inhibitorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Selectivity among monoamine oxidase inhibitors and its possible importance for development of antidepressant drugsProgress in Neuro-Psychopharmacology, 1978
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Relationship between the Action of Monoamine Oxidase Inhibitors on the Noradrenaline Uptake System and their Antidepressant EfficacyNature, 1968
- Clinical Trial of the Treatment of Depressive IllnessBMJ, 1965
- DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPYAmerican Journal of Psychiatry, 1964